|
|
- 2018
特应性皮炎患者嗜酸性粒细胞富集群中P物质及其受体NK1R的表达变化
|
Abstract:
摘要：目的 检测特应性皮炎(AD)患者外周血嗜酸性粒细胞富集群中P物质(SP)和NK1受体(NK1R)的表达，并分析其在AD中的可能作用。方法 采集健康对照组(HC)及AD患者的外周静脉血，用尘螨、蒿草花粉和梧桐花粉过敏原粗提液刺激1h后，流式细胞术检测嗜酸性粒细胞富集群中SP和NK1R的表达。结果 与HC组比较，静息状态下AD患者嗜酸性粒细胞富集群中NK1R+细胞的比例升高了41%(P=0.001)，SP+细胞的比例减少了1.17倍(P<0.001)，SP+细胞的MFI降低了55%(P<0.001)。过敏原对HC和AD患者嗜酸性粒细胞富集群中SP及NK1R表达的影响无统计学差异。结论 AD患者嗜酸性粒细胞富集群中NK1R表达上调，提示嗜酸性粒细胞表面的NK1R可能在特应性皮炎中起重要作用；NK1R拮抗剂或阻断剂可能是治疗AD的有效制剂。
ABSTRACT: Objective To investigate the expressions of substance P (SP) and neurokinin receptor (NK1R) in eosinophil-enriched cells from patients with atopic dermatitis (AD) so as to elucidate their possible roles in AD. Methods Blood samples were collected from healthy controls (HCs) and AD patients, and incubated with the extracts of Artemisia pollen, dust mite, and Platanus pollen for 1h. The expressions of SP and NK1R in eosinophil-enriched cells were detected by flow cytometry. Results Level of NK1R in eosinophil-enriched cells from AD patients increased by 41% compared with that of HCs when cultured with the medium only (P=0.001). In addition, the expression of SP in AD patients decreased by 1.17 folds (P<0.001), and mean fluorescence intensity (MFI) of SP+ eosinophils decreased by 55% (P<0.001). However, allergens had little effect on the expressions of SP and NK1R in eosinophil-enriched cells from AD patients and HCs. Conclusion Upregulated expression of NK1R in AD indicates that eosinophil-derived NK1R may play an important role in AD. Antagonists or blockers of NK1R might be effective preparations for AD treatment
| [1] | WOLLINA U. Microbiome in atopic dermatitis[J]. Clin Cosmet Investig Dermatol, 2017, 10:51-56. |
| [2] | PAVLOVIC S, LIEZMANN C, BLOIS SM, et al. Substance P is a key mediator of stress-induced protection from allergic sensitization via modified antigen presentation[J]. J Immunol, 2011, 186(2):848-855. |
| [3] | OHMURA T, TSUNENARI I, HAYASHI T, et al. Role of substance P in an NC/Nga mouse model of atopic dermatitis-like disease[J]. Int Arch Allergy Immunol, 2004, 133(4):389-397. |
| [4] | HE SH, ZHANG HY, ZENG XN, et al. Mast cells and basophils are essential for allergies: mechanisms of allergic inflammation and a proposed procedure for diagnosis[J]. Acta Pharmacol Sin, 2013, 34(10):1270-1283. |
| [5] | HENS G, RAAP U, VANOIRBEEK J, et al. Selective nasal allergen provocation induces substance P-mediated bronchial hyperresponsiveness[J]. Am J Respir Cell Mol Biol, 2011, 44(4):517-523. |
| [6] | NOH JY, SHIN JU, PARK CO, et al. Thymic stromal lymphopoietin regulates eosinophil migration via phosphorylation of l-plastin in atopic dermatitis[J]. Exp Dermatol, 2016, 25(11):880-886. |
| [7] | LIU P, ZHAO Y, MU ZL, et al. Clinical features of adult/adolescent atopic dermatitis and Chinese criteria for atopic dermatitis[J]. Chin Med J (Engl), 2016, 129(7):757-762. |
| [8] | FRIEDMAN S, LEVI-SCHAFFER F. Substance P and eosinophils: An itchy connection[J]. Exp Dermatol, 2015, 24(12):918-919. |
| [9] | PAVLOVIC S, DANILTCHENKO M, TOBIN DJ, et al. Further exploring the brain-skin connection: Stress worsens dermatitis via substance P-dependent neurogenic inflammation in mice[J]. J Invest Dermatol, 2008, 128(2):434-446. |
| [10] | RAAP M, RUDRICH U, STANDER S, et al. Substance P activates human eosinophils[J]. Exp Dermatol, 2015, 24(7):557-559. |
| [11] | EBNER K, SARTORI SB, SINGEWALD N. Tachykinin receptors as therapeutic targets in stress-related disorders[J]. Curr Pharm Des, 2009, 15(14):1647-1674. |
| [12] | ZHENG W, WANG J, ZHU W, et al. Upregulated expression of substance P in basophils of the patients with chronic spontaneous urticaria: Induction of histamine release and basophil accumulation by substance P[J]. Cell Biol Toxicol, 2016, 32(3):217-228. |
| [13] | TOYODA M, NAKAMURA M, MAKINO T, et al. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis[J]. Br J Dermatol, 2002, 147(1):71-79. |
| [14] | GARCIA-RECIO S, GASCON P. Biological and pharmacological aspects of the NK1-receptor[J]. Biomed Res Int, 2015, 2015:495704. |
| [15] | STEINHOFF MS, VON MENTZER B, GEPPETTI P, et al. Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease[J]. Physiol Rev, 2014, 94(1):265-301. |
| [16] | ZHAN M, ZHENG W, JIANG Q, et al. Upregulated expression of substance P (SP) and NK1R in eczema and SP-induced mast cell accumulation[J]. Cell Biol Toxicol, 2017, 33(4):389-405. |
| [17] | ZHANG ZN, ZHENG WJ, XIE H, et al. Up-regulated expression of substance P in CD8+ T cells and NK1R on monocytes of atopic dermatitis[J]. J Transl Med, 2017, 15(1):93. |
| [18] | ROSSO M, MUNOZ M, BERGER M. The role of neurokinin-1 receptor in the microenvironment of inflammation and cancer[J]. Scientific World Journal, 2012, 2012:381434. |
| [19] | GRUNDMANN S, STANDER S. Chronic pruritus: Clinics and treatment[J]. Ann Dermatol, 2011, 23(1):1-11. |
